Rockland Trust CO Pfizer Inc Transaction History

Rockland Trust CO

  • $2.01 Billion
  • Q3 2024

A detailed history of Rockland Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Rockland Trust CO holds 404,254 shares of PFE stock, worth $11.1 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
404,254
Previous 410,440 1.51%
Holding current value
$11.1 Million
Previous $11.5 Million 1.87%
% of portfolio
0.58%
Previous 0.61%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
SELL
$27.7 - $31.39 $171,352 - $194,178
-6,186 Reduced 1.51%
404,254 $11.7 Million
Q2 2024

Jul 23, 2024
BUY
$25.26 - $29.6 $154,338 - $180,856
6,110 Added 1.51%
410,440 $11.5 Million
Q1 2024

Apr 11, 2024
BUY
$25.89 - $29.73 $334,783 - $384,438
12,931 Added 3.3%
404,330 $11.2 Million
Q4 2023

Jan 11, 2024
BUY
$26.13 - $33.94 $1.53 Million - $1.99 Million
58,727 Added 17.65%
391,399 $11.3 Million
Q3 2023

Oct 26, 2023
BUY
$32.09 - $37.51 $194,369 - $227,198
6,057 Added 1.85%
332,672 $11 Million
Q2 2023

Jul 27, 2023
BUY
$36.12 - $41.79 $2.41 Million - $2.79 Million
66,751 Added 25.69%
326,615 $12 Million
Q1 2023

Apr 24, 2023
BUY
$39.39 - $51.28 $254,971 - $331,935
6,473 Added 2.55%
259,864 $10.6 Million
Q4 2022

Jan 24, 2023
BUY
$41.75 - $54.5 $17,201 - $22,454
412 Added 0.16%
253,391 $13 Million
Q3 2022

Oct 19, 2022
BUY
$43.76 - $53.42 $195,650 - $238,840
4,471 Added 1.8%
252,979 $11.1 Million
Q2 2022

Jul 13, 2022
SELL
$46.53 - $55.17 $673,056 - $798,034
-14,465 Reduced 5.5%
248,508 $13 Million
Q1 2022

Apr 18, 2022
BUY
$45.75 - $56.69 $785,390 - $973,197
17,167 Added 6.98%
262,973 $13.6 Million
Q4 2021

Jan 27, 2022
SELL
$41.32 - $61.25 $203,542 - $301,717
-4,926 Reduced 1.96%
245,806 $14.5 Million
Q3 2021

Oct 25, 2021
BUY
$39.25 - $50.42 $408,160 - $524,317
10,399 Added 4.33%
250,732 $10.8 Million
Q2 2021

Jul 21, 2021
BUY
$35.91 - $40.68 $110,243 - $124,887
3,070 Added 1.29%
240,333 $9.41 Million
Q1 2021

Apr 22, 2021
BUY
$33.49 - $37.77 $839,627 - $946,931
25,071 Added 11.82%
237,263 $8.6 Million
Q4 2020

Jan 04, 2021
SELL
$33.47 - $42.56 $31,662 - $40,261
-946 Reduced 0.44%
212,192 $7.81 Million
Q3 2020

Oct 08, 2020
SELL
$31.75 - $37.25 $115,252 - $135,217
-3,630 Reduced 1.67%
213,138 $7.82 Million
Q2 2020

Jul 09, 2020
SELL
$30.12 - $36.54 $235,146 - $285,267
-7,807 Reduced 3.48%
216,768 $7.09 Million
Q1 2020

Apr 16, 2020
SELL
$27.03 - $38.62 $151,800 - $216,889
-5,616 Reduced 2.44%
224,575 $7.33 Million
Q4 2019

Jan 06, 2020
SELL
$32.92 - $37.36 $593,646 - $673,712
-18,033 Reduced 7.26%
230,191 $9.02 Million
Q3 2019

Oct 11, 2019
BUY
$32.49 - $42.13 $1.65 Million - $2.14 Million
50,910 Added 25.8%
248,224 $8.8 Million
Q2 2019

Jul 05, 2019
BUY
$36.98 - $41.52 $240,148 - $269,630
6,494 Added 3.4%
197,314 $8.55 Million
Q1 2019

Apr 08, 2019
BUY
$37.5 - $41.2 $801,487 - $880,567
21,373 Added 12.61%
190,820 $8.1 Million
Q4 2018

Jan 16, 2019
BUY
$38.47 - $43.86 $34,507 - $39,342
897 Added 0.53%
169,447 $7.4 Million
Q3 2018

Oct 05, 2018
SELL
$34.47 - $41.81 $575,338 - $697,850
-16,691 Reduced 9.01%
168,550 $7.43 Million
Q2 2018

Jul 06, 2018
SELL
$32.98 - $35.16 $8,607 - $9,176
-261 Reduced 0.14%
185,241 $6.72 Million
Q1 2018

Apr 10, 2018
SELL
$31.91 - $37.02 $51,853 - $60,157
-1,625 Reduced 0.87%
185,502 $6.58 Million
Q4 2017

Jan 11, 2018
BUY
$33.26 - $35.29 $173,085 - $183,649
5,204 Added 2.86%
187,127 $6.78 Million
Q3 2017

Nov 01, 2017
BUY
$31.0 - $34.15 $5.64 Million - $6.21 Million
181,923
181,923 $6.5 Million

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rockland Trust CO Portfolio

Follow Rockland Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockland Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Rockland Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email